Foster & Motley Inc. Lowers Position in UnitedHealth Group Incorporated $UNH

Foster & Motley Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 4,874 shares of the healthcare conglomerate’s stock after selling 416 shares during the quarter. Foster & Motley Inc.’s holdings in UnitedHealth Group were worth $1,521,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Nabity Jensen Investment Management Inc grew its holdings in UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after purchasing an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC raised its position in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after buying an additional 25 shares in the last quarter. Osborne Partners Capital Management LLC increased its holdings in shares of UnitedHealth Group by 2.5% in the first quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock worth $558,000 after buying an additional 26 shares during the period. HHM Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after buying an additional 26 shares during the period. Finally, MPS Loria Financial Planners LLC increased its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock worth $3,800,000 after buying an additional 27 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $356.53 on Friday. The stock’s 50 day simple moving average is $329.38 and its two-hundred day simple moving average is $343.62. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $322.90 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the firm posted $6.80 earnings per share. The business’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price objective on the stock. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Piper Sandler cut their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Finally, Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.